Stock Ratings | Morgan Stanley raised its price target for Eli Lilly (LLY) to $1,347; Roth Capital initiated coverage of Annovis Bio (ANVS) with a buy rating, with a price target of $8, representing a potential upside of 302.01%.
TeraWulf Inc. WULF | 0.00 | |
Vera Therapeutics, Inc. Class A VERA | 0.00 | |
Tvardi Therapeutics Inc. TVRD | 0.00 | |
Annovis Bio Inc ANVS | 0.00 | |
Inuvo, Inc. INUV | 0.00 |
The ratings of major US investment banks are used to track the latest valuations and target prices on Wall Street daily, and to explore potential equity investment opportunities.
Risk warning:
Investing in small-cap stocks can be risky. Be prepared for potential challenges related to liquidity, high volatility, limited information, and financial instability. Always diversify your investments.
Today's key assessments and concerns
Morgan Stanley: Maintaining an "overweight" rating on TeraWulf ( TeraWulf Inc.(WULF.US) ), while raising the price target from $66.5 to $72.
HC Wainwright & Co.: Maintaining a "Buy" rating on Vera Therapeutics ( Vera Therapeutics, Inc. Class A(VERA.US) ), with a price target raised from $110 to $125.
Raymond James: Upgraded Tvardi Therapeutics ( Tvardi Therapeutics Inc.(TVRD.US) ) to "Outperform Market", with a price target of $10.
Roth Capital: Annovis Bio ( Annovis Bio Inc(ANVS.US) ) has an initial rating of "buy" on its stock, with a target price of $8.
Ladenburg Thalmann: Maintaining a "buy" rating on Inuvo stock ( Inuvo, Inc.(INUV.US) ), while lowering the price target from $4.25 to $4.
| The symbol | Classification | Target price | Current price | Percentage of potential increase/decrease | (Classification) Agency |
| TeraWulf Inc.(WULF.US) | to lift | $72.0 | $22.83 | 215.37% | Morgan Stanley |
| Vera Therapeutics, Inc. Class A(VERA.US) | to lift | $125.0 | $42.43 | 194.6% | HC Wainwright & Co. |
| Tvardi Therapeutics Inc.(TVRD.US) | to lift | $10.0 | $5.0 | 100.0% | Raymond James |
| MEIRAGTX HOLDINGS PLC(MGTX.US) | to lift | $26.0 | $14.14 | 83.88% | RBC Capital |
| Vera Therapeutics, Inc. Class A(VERA.US) | to lift | $78.0 | $42.43 | 83.83% | TD Securites |
| Annovis Bio Inc(ANVS.US) | Initial classification | $8.0 | $1.99 | 302.01% | Roth Capital |
| Inuvo, Inc.(INUV.US) | cut | $4.0 | $1.05 | 280.95% | Ladenburg Thalmann |
| Infinity Natural Resources, Inc. Class A(INR.US) | cut | $26.0 | $13.14 | 97.87% | Raymond James |
| Infinity Natural Resources, Inc. Class A(INR.US) | cut | $23.0 | $13.14 | 75.04% | Stephens & Co. |
| MarketAxess Holdings Inc.(MKTX.US) | cut | $200.0 | $117.14 | 70.74% | UBS |
comments:
Target price unit and current price: US Dollar;
Current price: As of the latest closing price of US stocks;
Potential percentage increase/potential decrease = (Agency target price - current price) / current price 100% (Current price = Last closing price up to the time of the count)
Lifting
Evercore ISI Group: Maintaining its "Outperform Market" rating for Dell Dell Technologies, Inc. Class C(DELL.US) stock, while raising its price target from $450 to $500.
Morgan Stanley: Maintaining an "overweight" rating on Johnson & Johnson Johnson & Johnson(JNJ.US) stock, while raising the price target from $283 to $284.
Morgan Stanley: Maintaining an "overweight" rating on Eli Lilly ( Eli Lilly and Company(LLY.US) ), while raising the price target from $1344 to $1347.
Susquehanna: Maintaining a "neutral" rating on Seagate Technology Seagate Technology Holdings PLC(STX.US) , while raising the price target from $615 to $775.
Susquehanna: Maintaining a "neutral" rating on Western Digital ( Western Digital Corporation(WDC.US) ), while raising the price target from $360 to $500.
First Coverage
Barclays: Initial rating for Mastercard Mastercard(MA.US) ) stock at "overweight", with a price target of $640.
DA Davidson: Initial rating for Snap Snap(SNAP.US) ) stock at "neutral", with a price target of $5.
Wells Fargo: Initial rating for Verizon ( Verizon Communications Inc.(VZ.US) ) at "market-weighted", with a price target of $43.
reduction
TD Cowen: Maintaining a "buy" rating on Amazon ( Amazon.com, Inc.(AMZN.US) ) stock, while lowering the price target from $350 to $340.
Benchmark: Maintaining a "buy" rating on CrowdStrike Holdings CrowdStrike(CRWD.US) ), while lowering the price target from $780 to $230.
Bernstein: Maintaining its "outperform" rating for Netflix Netflix(NFLX.US) ) stock, while lowering its price target from $110 to $100.
Editor's Note: This content was created by Saham's AI-powered SaaS tool and reviewed by our editorial team.
Risk Warning: Investing involves risk. Securities may rise, fall, or become worthless. Investing does not guarantee profits and may result in losses. Past performance is not necessarily indicative of future results. Before making any investment decision, investors should assess their financial situation, investment objectives, experience, risk tolerance, and understand the nature of the investment products and their associated risks. For more details on the nature and risks of each investment product, please read the relevant offering documents carefully. If you have any questions, it is advisable to seek independent professional advice.